Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 5Arthritis, Rheumatoid 2Lymphoma, Follicular 1Lung Neoplasms 1Fistula 1Adenocarcinoma of Lung 1

Interventions

Surgical Procedures, Operative 2Tomography, X-Ray Computed 1Stents 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Protons 1Octreotide 1Hydrocortisone 1Conservative Treatment 1Cholangiopancreatography, Endoscopic Retrograde 1Certolizumab Pegol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fistula × Certolizumab Pegol × Clear all
NCT00354367 2012-05-28

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

UCB Pharma

Phase 3 Withdrawn

Crohn Disease, Fistula

Data powered by HemOnc (CC BY 4.0) Colophon âš¡